Vaccine reagent kit for preventing carious tooth and method of use thereof
A kit and dental caries technology, applied in the field of vaccine kits for the prevention of dental caries, can solve the problems of serious side effects, can not be applied to human beings, and achieve strong immunogenicity, better immune effect, and strong specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] A vaccine kit for preventing dental caries, comprising an antigen and an adjuvant, the antigen being a recombinant plasmid co-expressing the surface protein antigen PAc of Streptococcus mutans caries and the glucosyltransferase GTF of Streptococcus mutans caries, the adjuvant being Salmonella flagellin.
[0034] The vaccine kit for preventing dental caries provided by the present invention, because the active component of the vaccine adopted is the recombinant plasmid encoding the surface protein antigen PAc and glucosyltransferase GTF of Streptococcus mutans, can encode the surface protein antigen PAc of Streptococcus mutans The exogenous genes of GTF and glucosyltransferase are directly introduced into the host cells, and the immune system of the host is induced to react to the surface protein antigen PAc and GTF of Streptococcus mutans to prevent dental caries. The vaccine has strong immunogenicity, can stimulate a comprehensive and durable immune response, and has s...
Embodiment 2
[0039] A vaccine kit for preventing dental caries, comprising an antigen and an adjuvant, the antigen being a recombinant plasmid co-expressing the surface protein antigen PAc of Streptococcus mutans caries and the glucosyltransferase GTF of Streptococcus mutans caries, the adjuvant being Salmonella flagellin; the plasmid vector of the recombinant plasmid is pVAX.
[0040] In other embodiments of the vaccine kit for preventing dental caries of the present invention, the plasmid vector of the recombinant plasmid can also be pcDNA3.0 or pcDNA3.1. pVAX, pcDNA3.0 or pcDNA3.1 meet the standards of the US FDA, and their use will not pose a safety threat to the users. The plasmid carrier of the recombinant plasmid described in the vaccine kit for preventing dental caries is most preferably pVAX, and the preventive effect of pVAX, pcDNA3.0 or pcDNA3.1 is the best.
Embodiment 3
[0042] The preparation method of the antigen in the dental caries prevention kit comprises:
[0043] (a) Treat the targeted fusion anti-caries eukaryotic expression plasmid pGJA-P with restriction enzymes NheI and NotI, excise the targeted fusion gene (including CTLA-4-Ig target gene, GLU, A-P fragment), and the target The fusion gene was cloned into the pVAX1 vector, digested to confirm the correctness of the construction, and named as pGJA-P / VAX.
[0044] (b) introducing the vector with the gene of interest into Escherichia coli DH5a competent cells;
[0045] (c) Cultivate the target strain on a large scale, and use the EndoFree Plasmid Maxi Kit to extract the plasmid in the target strain (the large plasmid QIAGEN kit has the function of removing endotoxin);
[0046] (e) using a spectrophotometer to measure the concentration of the purified plasmid DNA;
[0047] (f) Use Limulus reagent to detect whether the endotoxin content of the purified plasmid DNA exceeds the standard...
PUM
Property | Measurement | Unit |
---|---|---|
surface area | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com